The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The New York Academy of Sciences will co-host the inaugural PD Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only major scientific symposium exclusively focused on the development of innovative drugs to target Parkinson’s disease.
The conference will bring together academic and industry scientists to assess and discuss how novel scientific advances can be applied to accelerate the development of innovative drug discovery approaches to Parkinson’s disease.
“Our primary objectives for the conference are twofold: to discuss scientific progress on drug discovery initiatives aimed at better treating Parkinson’s disease, and to provide a new networking opportunity for scientists to share information and resources,” said conference chair C. Warren Olanow, M.D.